Incannex Healthcare (IXHL) Net Cash Flow (2023 - 2026)

Incannex Healthcare (IXHL) has reported Net Cash Flow for 4 consecutive years, with $2.3 million the latest figure, recorded in Q1 2026.

• Quarterly Net Cash Flow fell 51.2% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.6 million (up 2342.51% YoY) and the FY2025 annual result came in at $8.9 million, up 155.05% from the prior year.
• Net Cash Flow improved to $2.3 million in Q1 2026 per IXHL's latest filing, from -$3.7 million in the prior quarter.
• Over the last five years, Net Cash Flow for IXHL reached as high as $57.9 million in Q3 2025 and fell as low as -$6.0 million in Q3 2023.
• A 4-year average of $3.4 million and a median of -$2.3 million in 2024 frame the typical range for Net Cash Flow.
• The largest YoY upside for Net Cash Flow was 2622.2% in 2025 against a maximum downside of 136.77% in 2025.
• Year by year, Net Cash Flow stood at -$2.2 million in 2023, then grew by 28.17% to -$1.6 million in 2024, then tumbled by 136.77% to -$3.7 million in 2025, then soared by 161.22% to $2.3 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $2.3 million, -$3.7 million, and $57.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.